X0306 4/A 2017-12-07 2017-12-11 0 0000722830 IMMUNOMEDICS INC IMMU 0001677939 PEHL MICHAEL F. C/O IMMUNOMEDICS, INC 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 1 0 0 President and CEO Stock Options (right to buy) 11.86 2017-12-07 4 A 0 119237 0.0 A 2024-12-07 Common Stock, par value $0.01 per share 119237 119237 D Stock Options (right to buy) 11.86 2017-12-07 4 A 0 320139 0.0 A 2024-12-07 Common Stock, par value $0.01 per share 320139 320139 D The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter. The reporting person was granted performance-based vesting stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options will vest (i) as to 151,678 shares (a) 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter through the fourth anniversary of the date of grant (each date a "Vesting Date") and (b) subject to Immunomedics, Inc. common stock achieving a fair market value of $23.72 or higher based on the average closing price for the prior 15 consecutive trading days on such Vesting Date; and (ii) as to 168,461 shares (a) 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter through the fourth anniversary of the date of grant and (b) subject to Immunomedics, Inc. common stock achieving a fair market value of $35.58 or higher based on the average closing price for the prior 15 consecutive trading days on such Vesting Date. If the performance-based vesting criteria of the stock options is not attained on an applicable Vesting Date, and to the extent such performance-based vesting criteria is subsequently attained, the applicable tranche of stock options may vest on the date such criteria is met. The purpose of this amendment is to correct the number of shares reported in Table II, Column 5, Column 7 and Column 9. /s/ Michael F. Pehl 2017-12-22